Full video transcriptClick to expand
Auto-generated transcript of @hafthorbjornsonf's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Thanks for watching!
MK-677 and diet: what one month of use actually does
Quick answer
MK-677 is an investigational oral growth hormone secretagogue with documented IGF-1 elevation in clinical trials, but it carries real metabolic risks including increased fasting glucose and insulin resistance with chronic use. It is not FDA-approved, and its sale via supplement brands with influencer codes operates in a legal gray zone. Body composition changes attributed to MK-677 in 30-day anecdotal content cannot be separated from dietary change, training, water retention, and selection bias.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For MK-677 and diet: what one month of use actually does, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis
Used for PCOS pages comparing metabolic and weight-management approaches.
PubMed
The efficacy and safety of GLP-1 agonists in PCOS women living with obesity
Supports PCOS, obesity, and hormonal-regulation context.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
MK-677 and diet: what one month of use actually does is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "MK-677 and diet: what one month of use actually does" from hafthorbjornsonf. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: MK-677 is an investigational oral growth hormone secretagogue with documented IGF-1 elevation in clinical trials, but it carries real metabolic risks including increased fasting glucose and insulin resistance with chronic use.
The reason this review is not generic is the source wording and the canonical claim label "peptides what strict diet and mk 677 does in a month use code hjb10 f." In this clip, the useful excerpt is: "Thanks for watching!" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
MK-677 is an investigational oral growth hormone secretagogue with documented IGF-1 elevation in clinical trials, but it carries real metabolic risks including increased fasting glucose and insulin resistance with chronic use.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MK-677 is an investigational oral growth hormone secretagogue with documented IGF-1 elevation in clinical trials, but it carries real metabolic risks including increased fasting glucose and insulin resistance with chronic use. It is not FDA-approved, and its sale via supplement brands with influencer codes operates in a legal gray zone. Body composition changes attributed to MK-677 in 30-day anecdotal content cannot be separated from dietary change, training, water retention, and selection bias.
- MK-677 raises IGF-1 by roughly 40% at 25mg daily in clinical trials, but most data comes from older or GH-deficient populations, not healthy young athletes.
- Early weight changes on MK-677 are substantially driven by water retention, not new muscle tissue, which distorts before-and-after visual comparisons.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- MK-677 raises IGF-1 by roughly 40% at 25mg daily in clinical trials, but most data comes from older or GH-deficient populations, not healthy young athletes.
- Early weight changes on MK-677 are substantially driven by water retention, not new muscle tissue, which distorts before-and-after visual comparisons.
- Chronic MK-677 use at clinical doses worsened fasting glucose and insulin sensitivity in a two-year randomized trial (Nass et al., 2008, Annals of Internal Medicine).
- The ghrelin-mimetic mechanism of MK-677 increases appetite, which directly conflicts with the strict deficit dieting the creator describes.
- MK-677 is not FDA-approved and its classification as an investigational new drug means supplement-channel sales operate outside legal pharmaceutical frameworks.
- No peer-reviewed 30-day trial in healthy bodybuilders demonstrates the kind of transformation typically shown in this content format.
- Any interest in GH secretagogue therapy should begin with IGF-1 baseline testing and physician oversight, not a social media promo code.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What's this video probably claiming?
Based on the caption and hashtag context, this video likely shows a physique transformation or side-by-side comparison attributed to combining MK-677 (ibutamoren) with a strict caloric diet over roughly 30 days. The creator is almost certainly claiming visible muscle retention or gain alongside fat loss, framing MK-677 as the differentiating factor. There's a promo code attached to a supplement brand, which tells you something about the incentive structure here. Creators in this space routinely present MK-677 as a "safer" alternative to injectable growth hormone secretagogues, often implying it delivers similar anabolic effects without the needle. One month is also a suspiciously short window to attribute body composition changes to any single compound, especially one that primarily works through chronic GH pulse elevation.
What does the science actually show?
MK-677 is an oral ghrelin mimetic and growth hormone secretagogue that consistently raises IGF-1 levels in clinical trials. Nass et al. (2008, Annals of Internal Medicine) showed that 25mg daily for two years in older adults raised IGF-1 by roughly 40% and improved lean body mass modestly, but also increased fasting glucose and insulin resistance. Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) documented GH pulse amplification and increased fat-free mass in healthy older subjects at 25mg. The lean mass gains are real but modest, typically 1-3kg over 8-16 weeks in controlled studies, and much of that is water retained alongside glycogen due to elevated GH and cortisol. In a caloric deficit, MK-677 may support muscle preservation, but the data here is thin. No 30-day controlled trial demonstrates dramatic visual transformation attributable specifically to the compound.
Where does the social media noise diverge from clinical reality?
The gap between TikTok MK-677 content and actual trial data is significant. First, most clinical research used subjects who were older, GH-deficient, or in specific disease states, not healthy young bodybuilders. Extrapolating those results to a 25-year-old with normal GH output is a stretch the studies themselves don't support. Second, water retention from MK-677 is routinely misread as muscle gain on social media. The compound reliably increases extracellular water, which looks good in a before-and-after photo but isn't skeletal muscle. Third, increased hunger from ghrelin pathway activation is significant: Wren et al. (2001, Diabetes) showed ghrelin increases caloric intake acutely, which is a real challenge for anyone claiming they're in a "strict diet" simultaneously. That tension between appetite stimulation and caloric restriction is almost never addressed in creator content.
What should you actually know?
MK-677 is not FDA-approved for any indication. It is not a SARM, though it's often marketed alongside them. It is classified by the FDA as an investigational new drug, which means its sale as a supplement is legally questionable regardless of how it's labeled. The compound also raises concerns that get almost zero airtime in bodybuilding content: elevated fasting insulin and potential worsening of insulin sensitivity with chronic use (Nass et al., 2008), increased cortisol in some subjects, and water retention that can significantly impact cardiovascular load. Any vendor selling it with a discount code is operating outside regulated pharmaceutical channels. If you're interested in growth hormone optimization, that conversation belongs with a licensed clinician who can order an IGF-1 baseline and monitor for actual hormonal changes, not a promo code from a TikTok transformation video.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
hafthorbjornsonf · TikTok creator
5.9K views on this video
What Strict diet and Mk-677 does in a month use code HJB10 for 10% off on your @GRIND.LAB order 💪 🎯 #GymLife #StrengthTraining #Bodybuilding #GymTok #MK677
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about mk-677 raises igf-1 by roughly 40% at 25mg daily in?
MK-677 raises IGF-1 by roughly 40% at 25mg daily in clinical trials, but most data comes from older or GH-deficient populations, not healthy young athletes.
What does the video say about early weight changes on mk-677?
Early weight changes on MK-677 are substantially driven by water retention, not new muscle tissue, which distorts before-and-after visual comparisons.
What does the video say about chronic mk-677 use at clinical doses worsened fasting glucose?
Chronic MK-677 use at clinical doses worsened fasting glucose and insulin sensitivity in a two-year randomized trial (Nass et al., 2008, Annals of Internal Medicine).
What does the video say about the ghrelin-mimetic mechanism of mk-677 increases appetite,?
The ghrelin-mimetic mechanism of MK-677 increases appetite, which directly conflicts with the strict deficit dieting the creator describes.
What does the video say about mk-677?
MK-677 is not FDA-approved and its classification as an investigational new drug means supplement-channel sales operate outside legal pharmaceutical frameworks.
What does the video say about no peer-reviewed 30-day trial in healthy bodybuilders demonstrates the kind?
No peer-reviewed 30-day trial in healthy bodybuilders demonstrates the kind of transformation typically shown in this content format.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by hafthorbjornsonf, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.